Hedley Mary Lynne, an insider at Eli Lilly and Co (LLY), purchased 2,026 shares of the company's stock on November 16, 2025, at a price of $1,021.70 per share, totaling $2.07 million. Following this transaction, Hedley holds 2,026 shares of Eli Lilly.
Eli Lilly, a major player in the pharmaceuticals industry, specializes in the discovery, development, manufacture, and sale of various pharmaceutical products. The company, headquartered in Indianapolis, Indiana, has a market capitalization of $965.9 billion and boasts a P/E ratio of 52.46 and an EPS of 20.45. With a dividend yield of 58.7%, it continues to attract investor interest.
Insider transactions like this one are reported to the SEC, providing transparency into how executives view their company’s stock. While such purchases can indicate confidence in company prospects, they should be considered alongside other fundamental and technical factors. Investors are advised to observe patterns of insider activity over time rather than focusing on isolated transactions.
Eli Lilly is set to report its next earnings on April 28, 2026, with an EPS estimate of $7.16 and revenue expectations of $17.1 billion, followed by another report on August 4, 2026, with an EPS estimate of $7.86 and revenue of $18.7 billion.